Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
10:05am, Tuesday, 06'th May 2025
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Eli Lilly Stock Offers Buying Opportunity For Goldman Sachs. Concerns Over CVS Setback Are Overblown, Analysts Say
02:50pm, Friday, 02'nd May 2025
Eli Lilly and Co LLY on Thursday reported first-quarter earnings and lowered its 2025 guidance.
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
10:45am, Friday, 02'nd May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Stocks in the S&P 500 Index Have Done the Unthinkable and Rocketed at Least 45% This Year Despite Trump's Tariffs
04:15am, Friday, 02'nd May 2025
President Donald Trump's first 100 days proved tumultuous for the stock market. Trump instituted tariffs in his bid to bring more manufacturing jobs back to the U.S. and shake up global trade.
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
02:21pm, Thursday, 01'st May 2025
Novo Nordisk A/S NVO announced that CVS Health Inc's CVS CVS Caremark, a Pharmacy Benefit Manager (PBM), has decided that Wegovy (semaglutide) injection 2.4 mg will soon be the preferred GLP-1 med
CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone
01:56pm, Thursday, 01'st May 2025
Eli Lilly and Company's stock fell over 11% after CVS Caremark excluded Lilly's obesity drug Zepbound from its standard commercial formularies starting July 1, 2025. The market overreacted to CVS's ex
CVS earnings: Things are finally clicking for the healthcare giant
01:33pm, Thursday, 01'st May 2025
CVS (CVS) stock jumped after beating first quarter earnings and revenue expectations. Jefferies Healthcare Services equity research analyst Brian Tanquilut explains how CVS's margin recovery and busin
Initial Claims More Than Expectations
12:10pm, Thursday, 01'st May 2025
Initial Claims More Than Expectations.
CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy
11:30am, Thursday, 01'st May 2025
CVS Health Corporation's Q1 2025 earnings show strong growth, with revenues up 7% YoY and adjusted EPS up 72%, but caution is advised for the long-term outlook. Despite positive quarterly results, CVS
CVS Health (CVS) Q1 2025 Earnings Call Transcript
11:16am, Thursday, 01'st May 2025
CVS Health Corporation (NYSE:CVS ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President,
CVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance
11:11am, Thursday, 01'st May 2025
CVS Health Corp CVS reported first-quarter sales of $94.59 billion on Thursday, beating the consensus of $93.64 billion.
CVS Health raises full-year profit outlook as Q1 earnings top estimates
10:37am, Thursday, 01'st May 2025
CVS Health Corp (NYSE:CVS) shares rose after the pharmacy chain raised its full-year profit guidance and delivered strong financial results for the first quarter. The company now expects 2025 adjusted
Compared to Estimates, CVS Health (CVS) Q1 Earnings: A Look at Key Metrics
10:36am, Thursday, 01'st May 2025
While the top- and bottom-line numbers for CVS Health (CVS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare
QCOM Earnings Sell-Off, CVS Turnaround Continues, LLY Disappoints
10:30am, Thursday, 01'st May 2025
While Microsoft (MSFT) and Meta Platforms (META) shined in the Big Tech space, Diane King Hall turns to a mixed earnings picture elsewhere on Wall Street. CVS Health (CVS) posted an earnings beat, rai
CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up
10:15am, Thursday, 01'st May 2025
CVS Health delivers earnings and revenue beat in the first quarter of 2025.
